Verbio SE

Verbio SE

28.28
EUR
+0.86
(+3.14%)
-1.15EPS
2.90BMarket Cap
Nov 12Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
11.19
11.65
9.82
10.39
11.53
10.89
12.37
13.85
16.27
28.66
31.03
26.09
24.83
27.04
Basic EPS, GAAP
-2.42
0.08
0.43
0.77
0.82
0.24
0.84
1.01
1.48
4.99
2.08
0.31
-2.17
-1.14
Free Cash Flow per Basic Share
-0.89
1.09
0.52
1
0.9
-0.23
-0.28
0.06
0.79
3.32
-2.79
-0.86
-1.87
0.33
Dividend per Share
- -
- -
- -
0.1
0.15
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
- -
Book Value per Share
2.82
2.91
3.32
4.03
4.69
4.75
5.38
6.18
8.04
12.87
14.32
14.55
11.71
12.07
Tangible Book Value per Share
2.81
2.9
3.32
4.02
4.68
4.74
5.37
6.17
8.03
12.86
14.3
14.53
11.69
12.04
Basic Weighted Avg Shares
63
63
63
63
63
63
63
63
63
63
63
64
64
66
Sales/Revenue/Turnover
705
734
618
654
726
686
779
872
1,026
1,812
1,968
1,658
1,580
1,774
Operating Margin (%)
-2.8
1.18
3.94
7.41
9.56
3.45
9.88
10.78
15.2
25.64
9.82
3.9
-8.63
-3.42
Depreciation Expense
26
26
22
21
22
22
21
30
30
33
42
52
67
68
Net Income, GAAP
-153
5
27
49
51
15
53
63
93
316
132
20
-138
-75
Effective Tax Rate (%)
- -
21
- -
3.35
26.59
31.91
29.29
29.88
30.88
31.2
33.67
66.58
- -
- -
Profit Margin (%)
-21.63
0.72
4.33
7.45
7.09
2.18
6.8
7.27
9.08
17.41
6.71
1.2
-8.74
-4.23
Working Capital
25
29
50
91
140
136
132
166
243
404
384
369
251
258
LT Debt
31
22
12
2
1
- -
- -
43
41
44
135
173
195
199
Total Equity
178
184
210
254
296
300
339
391
510
818
912
928
746
769
Return on Invested Capital (%)
- -
2.98
- -
19.8
17.56
4.85
15.66
15.82
18.15
40.99
12.66
2.06
- -
- -
Return on Capital (%)
- -
3.17
- -
20.19
18.35
5.02
16.86
16.27
18.86
44.61
13.52
2.08
- -
- -
Return on Common Equity (%)
- -
2.92
13.66
21.07
18.76
5.02
16.6
17.4
20.78
47.67
15.3
2.18
-16.51
-9.15

Capital Structure

EUR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
104
95
29
LT Borrowings
173
173
176
LT Finance Leases
20
19
23
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
64
64
64
Market Capitalization
724
1,186
2,900

Working Capital

EUR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
556
532
541
Cash, Cash Equivalents & STI
72
78
77
Accounts Receivable, Net
106
107
110
Inventories
297
277
258
Total Current Liabilities
312
303
283
Payables & Accruals
- -
- -
- -
ST Debt
104
95
29
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.19%
16.92%
-19.6%
Free Cash Flow
134.07%
296.36%
119.1%
Net Income, GAAP
-35.75%
-129.76%
-791.44%
Sales/Revenue/Turnover
11.92%
16.48%
-4.72%
Total Cash Common Dividend
- -
- -
0.2%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
488
421
409
340
1,658
2025
358
394
395
433
1,580
2026
438
455
447
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.34
0.02
-0.18
0.13
0.31
2025
-0.36
-0.06
-0.22
-1.53
-2.17
2026
-0.06
0.05
0.36
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.2
2025
- -
- -
- -
- -
0.2
2026
- -
- -
- -
- -
- -

Company Description

CEO
Claus Sauter
Full Time Employees
1,391
Sector
Process industries
Industry
Chemicals: specialty
Address
Ritterstrasse 23 Leipzig SX Germany 04109
IPO Date
Nov 14, 2007
Website
verbio.de
Business
VERBIO Vereinigte BioEnergie AG, now operating as Verbio SE following its conversion to a European public limited company in November 2023, produces and distributes biofuels and bio-based products from sustainable biomass including rapeseed oil, grains, and straw. The company offers biodiesel (verbiodiesel), bioethanol (verbioethanol), biomethane (verbio gas), and bioCNG/bioLNG; pharma-glycerine (verbioglycerin); olefin metathesis catalysts; animal feeds such as Verbio Proti Flow and Verbio Grain Pro; phytosterols under the Sterocellent brand; liquid fertilizers; and bio-based chemicals via ethenolysis technology. It provides transport, logistics, and BioCNG/BioLNG filling station services across 25 stations in Germany; its products serve fuels, cosmetics, food, pharmaceuticals, power generation, agriculture, and chemical industries. Founded in 2001 with shares listed since 2006, Verbio SE maintains headquarters in Zörbig, Germany, administrative offices in Leipzig, and production sites in Europe (Germany, Poland, Hungary), North America (USA, Canada), and Asia (India) with over 1,450 employees. Recent developments include the successful ramp-up of its combined bioethanol-biomethane plant in Nevada, Iowa, USA, acquired in 2023 for US$230 million and brought online in fiscal year 2024/25; EUR 125 million in investments for capacity expansions, bio-based chemicals production in Bitterfeld, Germany (commissioning 2026, targeting 60,000 tonnes annually), and catalyst facility groundbreaking in Hungary (EUR 27.7 million investment); a partnership with Nippon Gases for CO2 utilization from bioethanol processes at Zörbig and planned for Schwedt/Oder; biofuel production exceeding 1.2 million tonnes of biodiesel/bioethanol and 1,190 GWh biomethane in fiscal 2024/25; and expectations for significant EBITDA recovery in fiscal 2025/26 amid market normalization under RED III regulations.

Company News

  • Verbio (OTCMKTS:VBVBF) Stock Falls 11.2% – Should You Sell?

  • Verbio SE (VBVBF) Q4 2026 Earnings Call Transcript

  • Verbio SE (VBVBF) Q3 2026 Earnings Call Transcript

  • Middle East war propels demand for local biofuel, Verbio CEO says

  • Verbio (OTCMKTS:VBVBF) Stock Price Down 13.2% – Here’s Why

  • Verbio SE (VBVBF) Q2 2026 Earnings Call Transcript

  • Verbio SE (VBVBF) Q1 2026 Earnings Call Transcript

  • Verbio SE (VBVBF) Q4 2025 Earnings Call Transcript

  • Verbio SE (VBVBF) Q3 2025 Earnings Conference Call Transcript

  • Verbio SE (VBVBF) Q2 2025 Earnings Call Transcript

  • Verbio SE (VBVBF) Q1 2025 Earnings Call Transcript

  • VERBIO SE (VBVBF) Q3 2024 Earnings Call Transcript